NASDAQ: PALI
Palisade Bio Inc Stock Ownership - Who owns Palisade Bio?

Insider buying vs selling

Have Palisade Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PALI insiders and whales buy or sell their stock.

PALI Shareholders

What type of owners hold Palisade Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Richard Garr1.33%1,986,304$4.27MInsider
Regional Medical Center Yuma1.22%1,814,375$3.90MInsider
Princeton Capital Corp0.87%1,293,814$2.78MInsider
Stanley Westreich0.80%1,193,281$2.57MInsider
Karl Johe0.62%930,373$2.00MInsider
Robert J. Trenschel0.21%315,399$678.11kInsider
Sandford D. Smith0.15%219,916$472.82kInsider
John Conron0.08%115,492$248.31kInsider
Catherine A. Sohn0.07%106,952$229.95kInsider
Scott Varde Ogilvie0.06%86,020$184.94kInsider

1 of 3

PALI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PALI0.08%5.55%
ALDX65.22%27.77%Net Selling
XOMA18.93%81.07%Net SellingNet Buying
ACIU24.41%0.00%
AVXL36.53%4.97%Net Buying

Palisade Bio Stock Ownership FAQ

Who owns Palisade Bio?

Palisade Bio (NASDAQ: PALI) is owned by 0.08% institutional shareholders, 5.55% Palisade Bio insiders, and 94.37% retail investors. Richard Garr is the largest individual Palisade Bio shareholder, owning 1.99M shares representing 1.33% of the company. Richard Garr's Palisade Bio shares are currently valued at $4.27M.

If you're new to stock investing, here's how to buy Palisade Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.